UNC0631

CAS No. 1320288-19-4

UNC0631( UNC0631, UNC 0631, UNC-0631 )

Catalog No. M17245 CAS No. 1320288-19-4

UNC0631 is a effectvie histone methyltransferase G9a inhibitor (IC50=4 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 93 In Stock
10MG 148 In Stock
25MG 297 In Stock
50MG 458 In Stock
100MG 668 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    UNC0631
  • Note
    Research use only, not for human use.
  • Brief Description
    UNC0631 is a effectvie histone methyltransferase G9a inhibitor (IC50=4 nM).
  • Description
    UNC-0631 is a novel G9a inhibitor with excellent potency in a variety of cell lines and excellent separation of functional potency versus cell toxicity. Protein lysine methyltransferase G9a plays key roles in the transcriptional repression of a variety of genes via dimethylation of lysine 9 on histone H3 (H3K9me2) of chromatin as well as dimethylation of nonhistone proteins including tumor suppressor p53.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    UNC0631, UNC 0631, UNC-0631
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    G9a
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    1320288-19-4
  • Formula Weight
    635.93
  • Molecular Formula
    C37H61N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 16.67 mg/mL. 26.21 mM; H2O : < 0.1 mg/mL
  • SMILES
    COc1c(OCCCN2CCCCC2)cc2nc(nc(NC3CCN(CC4CCCCC4)CC3)c2c1)N1CCCN(CC1)C(C)C
  • Chemical Name
    N-(1-(cyclohexylmethyl)piperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Liu F, et al. J Med Chem. 2011, 54(17), 6139-6150.
molnova catalog
related products
  • PD153035 hydrochlori...

    PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.

  • Mutated EGFR-IN-1

    Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.

  • BI-4020

    BI-4020 is a fourth-generation, non-covalent, and orally active inhibitor of EGFR tyrosine kinase.